A salamander can lose a leg and grow a new one. Cut a zebrafish's fin and it simply builds another. Mammals, us included, got the consolation prize: a scar. For a century, biologists assumed that somewhere on the evolutionary road to becoming warm-blooded, fast-moving animals, we traded regeneration away for good.
Two research teams working on opposite sides of the planet have just made that assumption look wrong. The headline is almost hard to believe: the ability to regrow lost body parts may not have been deleted from our biology at all. It may simply have been switched off, and switches can be flipped back on.
The genetic "remote control" that stopped working
The first clue comes from a team at the National Institute of Biological Sciences in Beijing, working with genomics powerhouse BGI-Research. Publishing in Science, they zeroed in on a gene called ALDH1A2, the instruction sheet for an enzyme that turns vitamin A into retinoic acid, a molecule that acts like a foreman on a construction site, telling cells where to go and what to build during tissue repair.
Animals that regenerate freely crank this gene up at the wound site. Mice, it turns out, still carry the same gene. They've just lost the genetic "remote controls," the regulatory DNA that tells the gene to fire after an injury. The hardware is intact; the software command was disconnected somewhere in evolution.
So the researchers reconnected it. By reactivating that dormant switch and restoring the flow of retinoic acid, they got mice to regenerate damaged outer-ear tissue, something a normal mouse simply cannot do. In their own words, they had found "a genetic switch involved in the evolution of regeneration."
Meanwhile, in Texas, they regrew a limb joint
The second piece of evidence lands the point with force. At Texas A&M, a group led by Dr. Ken Muneoka took a different route to the same destination. Instead of editing a genetic switch, they used a precisely timed sequence of two signaling proteins. First, FGF2 to steer cells away from forming a scar and toward a regenerative "blastema" (the same seed structure salamanders use), then BMP2 to tell those cells to start building.
The result: mice regrew bone, joints, ligaments, and tendons after amputation of a digit. Not a perfect anatomical copy, but real, structured, living tissue where scar should have been. As one of the researchers put it, the capacity for regeneration "is not absent, just obscured."
Two teams. Two completely different methods. One shared, startling conclusion: the regeneration program is still in there.
What this could change
It is easy to be numb to medical breakthroughs. Most are a single molecule, in a single dish, a decade from anyone's clinic. This is different in a way that matters for anyone thinking about where R&D is heading.
First, it reframes an entire problem. For decades, regenerative medicine has largely meant importing repair: transplanting stem cells, growing tissue on scaffolds, engineering replacement parts from the outside in. These studies suggest a radically cheaper path. Don't add anything, just un-silence what the body already knows how to do. The instructions ship with the organism.
Second, the tools are already halfway to the clinic. The two growth factors used in the Texas work, FGF2 and BMP2, are already FDA-approved or in human trials for other uses. That collapses one of the longest, most expensive stretches of the drug-development timeline: the part where a promising idea dies waiting for a safe delivery method.
Third, and most provocative: if a dormant regenerative program is a general feature of mammals rather than a quirk of ears or fingertips, the same logic could eventually point at the things that actually fill hospitals. Heart muscle after a heart attack, spinal cord after injury, the slow scarring of aging organs. That is still a long road. But the map just changed.
The R&D takeaway
The pattern here is one every innovator should keep close. The biggest breakthroughs are not always about inventing something new. Sometimes they come from discovering that the capability was there the whole time, quietly disabled, waiting for someone to ask a better question: not "how do we build this?" but "why did nature turn this off, and what happens if we turn it back on?"
Evolution optimized us for fast healing and survival, and regeneration lost out. But "lost" and "switched off" are very different things, and in 2026, that distinction may turn out to be one of the most valuable in medicine.
Dare to dream. Dare to flip the switch.
Sources: "Reactivation of mammalian regeneration by turning on an evolutionarily disabled genetic switch," National Institute of Biological Sciences (Beijing) and BGI-Research, published in Science; digit-regeneration research led by Dr. Ken Muneoka, Texas A&M University, reported by ScienceDaily.
Top comments (0)